Esther graduated with a Bachelor of Biomedical Sciences (Honours) from The University of Queensland in 2018, majoring in Pharmacology. She then joined the Ruitenberg Group as a Research Assistant in early 2019 where she currently works on clinical studies aimed at identifying peripheral biomarkers of spinal cord injury (SCI), and also the therapeutic use of intravenous immunoglobulin (IVIG) in acute SCI.